P & G Health Ltd

48
Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE199A01012
  • NSEID: PGHL
  • BSEID: 500126
INR
5,602.70
68 (1.23%)
BSENSE

Nov 20

BSE+NSE Vol: 24.41 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Jun'24
Jun'23
Jun'22
Jun'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025

Compare Profit and Loss Results of P & G Health Ltd
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,407.00
1,797.00
-390.00
-21.70%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,407.00
1,797.00
-390.00
-21.70%
Expenditure (Ex Depriciation)
Stock Adjustments
-12.00
-62.00
50.00
80.65%
Raw Materials Consumed
377.00
883.00
-506.00
-57.30%
Power & Fuel Cost
7.00
87.00
-80.00
-91.95%
Employee Cost
222.00
170.00
52.00
30.59%
Operating Expenses
90.00
219.00
-129.00
-58.90%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
106.00
8.00
98.00
1,225.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
21.00
58.00
-37.00
-63.79%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
951.00
1,424.00
-473.00
-33.22%
Operating Profit (PBDIT) excl Other Income
456.00
372.00
84.00
22.58%
Other Income
17.00
15.00
2.00
13.33%
Operating Profit (PBDIT)
474.00
388.00
86.00
22.16%
Interest
0.00
46.00
-46.00
-100.00%
Profit before Depriciation and Tax
473.00
341.00
132.00
38.71%
Depreciation
23.00
104.00
-81.00
-77.88%
Profit Before Taxation & Exceptional Items
449.00
237.00
212.00
89.45%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
449.00
234.00
215.00
91.88%
Provision for Tax
122.00
58.00
64.00
110.34%
Profit After Tax
326.00
176.00
150.00
85.23%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
159.00
1,266.00
-1,107.00
-87.44%
Profit Available for appropriations
486.00
1,442.00
-956.00
-66.30%
Appropriations
486.00
1,442.00
-956.00
-66.30%
Equity Dividend (%)
2050%
70%
1,980.00
Earnings Per Share
197
19.44
177.56
913.37%
Profit And Loss - Net Sales
Net Sales 1,407.97 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 50.72% vs NA in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 456.66 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 43.43% vs NA in Mar 2025

Profit And Loss - Interest
Interest 0.55 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 27.91% vs NA in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 326.91 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 39.46% vs NA in Mar 2025